EUVIMEDEUVIMED entdecken
Crossref

Outcomes of ABO-Incompatible Living Donor Kidney Transplantation Compared to Waiting or Deceased Donor Kidney Transplantation

Tai Yeon Koo, Juhan Lee, Yonggu Lee, Hyung Woo Kim, Beom Seok Kim, Kyu Ha Huh, Jaeseok Yang

American Journal of Nephrology · 2024 · 55 (2) · 235-244

DOI: 10.1159/000535583 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Nephrology, online erschienen am 30.11.2023. Verfasst von Tai Yeon Koo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Korea University Anam Hospital, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Kidney Transplantation. Die Arbeit wurde bisher 11-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

ABO-incompatible (ABOi) living donor kidney transplantation (LDKT) is considered only for patients who do not have an ABO-compatible (ABOc) LD. Therefore, a clinically practical question is whether to proceed with ABOi LDKT or remain on dialysis while waiting for ABOc deceased donor kidney transplantation (DDKT). However, this issue has not been addressed in Asian countries, where ABOi LDKT programs are more active than DDKT programs.

Methods

A total of 426 patients underwent ABOi-LDKT between 2010 and 2020 at Seoul National University Hospital and Severance Hospital, Korea. We compared outcomes between the ABOi-LDKT and the propensity-matched control groups (waiting-list-only group, n = 1,278; waiting-list-or-ABOc-DDKT group, n = 1,278).

Results

The ABOi-LDKT group showed a significantly better patient survival rate than the waiting-list-only group (p = 0.001) and the waiting-list-or-ABOc-DDKT group (p = 0.048). When the ABOi-LDKT group was categorized into a high-titer group (peak anti-ABO titer ≥1:128) and a low-titer group (peak anti-ABO titer ≤1:64), the low-titer group showed better patient survival rates than those of the waiting-list-or-ABOc-DDKT group (p = 0.046) or the waiting-list-only group (p = 0.004). In contrast, the high-titer ABOi-LDKT group showed no significant benefit in patient survival compared to the waiting-list-or-ABOc-DDKT group. Death-censored graft survival in the ABOi-LDKT group was not significantly different from that in the ABOc-DDKT group (p = 0.563).

Conclusion

The ABOi-LDKT group has better outcomes than the waiting-list-or-ABOc-DDKT group in a country with a long waiting time.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney TransplantationHumansLiving DonorsBlood Group IncompatibilityGraft RejectionKidneyABO Blood-Group SystemGraft Survival

Stichwörter der Autor:innen

ABO-incompatible transplantationAnti-ABO antibody titerDeceased donorKidney transplantation

Substanzen

ABO Blood-Group System

Autor:innen und Institutionen

  • Department of Internal Medicine, Korea University Anam Hospital, Seoul, Republic of Korea.
  • Department of Surgery, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • The Research Institute for Transplantation, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Department of Internal Medicine, Hanyang University Guri Hospital, Gyeonggi-do, Republic of Korea.
  • Division of Nephrology, Department of Internal Medicine, Yonsei University College of Medicine, Severance Hospital, Seoul, Republic of Korea.

Zitieren

APA

Koo, T. Y., Lee, J., Lee, Y., Kim, H. W., Kim, B. S., Huh, K. H., & Yang, J. (2024). Outcomes of ABO-Incompatible Living Donor Kidney Transplantation Compared to Waiting or Deceased Donor Kidney Transplantation. American Journal of Nephrology, 55(2), 235-244. https://doi.org/10.1159/000535583

Vancouver

Koo TY, Lee J, Lee Y, Kim HW, Kim BS, Huh KH, et al. Outcomes of ABO-Incompatible Living Donor Kidney Transplantation Compared to Waiting or Deceased Donor Kidney Transplantation. American Journal of Nephrology. 2024;55(2):235-244. doi:10.1159/000535583

BibTeX
@article{Koo2024,
  author = {Koo, Tai Yeon and Lee, Juhan and Lee, Yonggu and Kim, Hyung Woo and Kim, Beom Seok and Huh, Kyu Ha and Yang, Jaeseok},
  title = {Outcomes of ABO-Incompatible Living Donor Kidney Transplantation Compared to Waiting or Deceased Donor Kidney Transplantation},
  journal = {American Journal of Nephrology},
  year = {2024},
  volume = {55},
  number = {2},
  pages = {235--244},
  doi = {10.1159/000535583}
}
Kostenlos starten →